Malaria: Moment of decision for east African countries
Invitation to press conference.
11 February 2002
Will countries be forced to treat malaria with 'placebos'? Today MSF releases report that does the maths to see if we can afford to eliminate needless deaths from Africa’s number one killer of children When: Wednesday, 13 February 2002, 11.00am When: Press Centre, Chester House, Koinange Street, Nairobi
With rising resistance to current medication for malaria, today, for the first time, an MSF white paper lays out the actual costs of going to effective drugs instead of placebo-like choices. The price tag is surprisingly affordable but donors are still balking.
At the conclusion of a three day EANMAT* meeting, the regions’ leading malaria experts from Kenya, Uganda, Tanzania, Rwanda and Burundi will reassert that resistance to the mainstay malaria medicines is rising. This means that more and more young children and adults with malaria are dying because national protocol drugs are no longer working.
These experts are likely to be forced to offer protocols with mostly the same old drugs because the newer artemisinin drugs are thought to be too expensive and they cannot afford them without outside help.
Today an MSF doctor working in Burundi will speak about her experiences in the clinic and the life and death consequences of the decision at hand.
Also we will ask why WHO/Roll Back Malaria and USAID are not actively backing implementation of the recommended strategy? Is politics leading to bad medicine?
Dr. Diane Cheynier, MSF medical doctor working in a health clinic in Bujumbura, Burundi
Dr. Jean-Marie Kindermans, MSF Access to Essential Medicines Campaign, responsible for malaria and lead author of white paper released today.
Amanda Harvey, MSF Field Support for the region
Dr Suna Balkan, MSF doctor responsible for malaria